Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLNE | Common Stock | Options Exercise | $241K | +48K | +11.42% | $5.02 | 468K | Jun 15, 2021 | Direct | F2 |
transaction | CLNE | Common Stock | Sale | -$1.95M | -168K | -35.83% | $11.62 | 301K | Jun 15, 2021 | Direct | F1, F2 |
transaction | CLNE | Common Stock | Sale | -$39.8K | -3.3K | -1.1% | $12.06 | 297K | Jun 15, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLNE | Stock Option (Right to Buy) | Options Exercise | $0 | -48K | -100% | $0.00* | 0 | Jun 15, 2021 | Common Stock | 48K | $5.02 | Direct | F2 |
Id | Content |
---|---|
F1 | Shares were sold in multiple transactions at prices ranging from $11.05 to $12.04, inclusive. The price reported in Column 4 is a weighted average sale price. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
F2 | The stock option exercise and the subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2021. |